Subscribe

AS Partners Co. Ltd. (160A.T)

JPY2,098.00 +22.00 (+1.06%)
JP JPX Healthcare Medical - Care Facilities
Address 11th Floor, Ochanomizu Kyoun Building
Tokyo, JP
CEO Kenji Uemura
Website as-partners.co.jp
IPO 2024-04-04
ISIN JP3119840001

Explore sections of this company profile

Description

AS Partners Co. Ltd. focuses on delivering comprehensive senior care solutions. The company's services include operating long-term residential nursing facilities, providing assistance with daily living activities, offering temporary respite care, and a range of other related support. Beyond direct care provision, AS Partners is also engaged in the development and management of specialized real estate for the elderly, including nursing homes, and offers condominium rental services. Takeshi Uemura established the company on November 2, 2004, and its main office is situated in Tokyo, Japan.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY2,098.00 +22.00 (+1.06%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
15.5K
Beta
0.73
Float Shares
1.04M
Free Float %
29.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+10.82% +7.42% +0.51% -13.23% -18.08% -15.29% -1.76% -10.40% -10.40% -10.40% -10.40%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
2,098.00
Ratings Trend (MoM)
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.68
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +32.1% ★ Q1'26: +21.7% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +22.9% ★ Q1'26: -11.1% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +17.8% ★ Q1'26: +0.0% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +6.4% Q1'26: -1.8% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +10.0% ★ Q1'26: -1.8% (vs Q1'25)
  • ✗
    Share dilution Medical - Care Facilities: +0.0%
    +0.8% Q1'26: -1.3% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    5.83× Q1'26: -1,250.57× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.71) × ERP
WACC = 44% × Ke + 56% × Kd (4.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 2,098.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2024
actual 		Mar 2025
actual 		Mar 2026
1 Rev. Ana.
1 EPS Ana. 		Mar 2027
1 Rev. Ana.
1 EPS Ana. 		Mar 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
17.15B
est: 17.12B (+0.2%)
17.92B
est: 18.30B (-2.1%)
24.00B
24.00B – 24.00B
+31.1% YoY
26.50B
26.50B – 26.50B
+10.4% YoY
29.00B
29.00B – 29.00B
+9.4% YoY
EBITDA
1.08B
est: 1.23B (-12.0%)
1.64B
est: 1.31B (+25.3%)
1.72B
1.72B – 1.72B
+31.1% YoY
1.90B
1.90B – 1.90B
+10.4% YoY
2.08B
2.08B – 2.08B
+9.4% YoY
EBIT
916.62M
est: 1.04B (-12.0%)
1.43B
est: 1.11B (+28.7%)
1.46B
1.46B – 1.46B
+31.1% YoY
1.61B
1.61B – 1.61B
+10.4% YoY
1.77B
1.77B – 1.77B
+9.4% YoY
Net Income
563.57M
est: 599.87M (-6.1%)
956.66M
est: 956.77M (0.0%)
1.06B
1.06B – 1.06B
+11.0% YoY
1.18B
1.18B – 1.18B
+11.3% YoY
1.38B
1.38B – 1.38B
+16.9% YoY
SGA
2.30B
est: 1.70B (+35.2%)
1.99B
est: 1.82B (+9.4%)
2.39B
2.39B – 2.39B
+31.1% YoY
2.64B
2.64B – 2.64B
+10.4% YoY
2.89B
2.89B – 2.89B
+9.4% YoY
EPS
186.00
est: 167.15 (+11.3%)
269.74
est: 266.60 (+1.2%)
296.00
296.00 – 296.00
+11.0% YoY
329.50
329.50 – 329.50
+11.3% YoY
385.30
385.30 – 385.30
+16.9% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-15 B 3/5 1/5 5/5 4/5 1/5 3/5 3/5
2026-05-14 B 3/5 1/5 5/5 4/5 1/5 3/5 3/5
2026-05-13 B 3/5 1/5 5/5 4/5 1/5 3/5 3/5
2026-05-12 B 3/5 1/5 5/5 4/5 1/5 3/5 3/5
2026-05-11 B 3/5 1/5 5/5 4/5 1/5 3/5 3/5
2026-05-08 B+ 3/5 1/5 5/5 4/5 1/5 4/5 3/5
2026-05-07 B+ 3/5 1/5 5/5 4/5 1/5 4/5 3/5
2026-05-01 B+ 3/5 1/5 5/5 4/5 1/5 4/5 3/5
2026-04-30 B+ 3/5 1/5 5/5 4/5 1/5 4/5 3/5
2026-04-28 B+ 3/5 1/5 5/5 4/5 1/5 4/5 3/5
2026-04-27 B+ 3/5 1/5 5/5 5/5 1/5 4/5 3/5
2026-04-24 B+ 3/5 1/5 5/5 5/5 1/5 4/5 3/5
2026-04-23 B+ 3/5 1/5 5/5 5/5 1/5 3/5 3/5
2026-04-22 B+ 3/5 1/5 5/5 5/5 1/5 3/5 3/5
2026-04-21 B+ 3/5 1/5 5/5 5/5 1/5 3/5 3/5
2026-04-20 B+ 3/5 1/5 5/5 5/5 1/5 3/5 3/5
2026-04-17 B+ 3/5 1/5 5/5 5/5 1/5 3/5 3/5
2026-04-16 B+ 3/5 1/5 5/5 5/5 1/5 3/5 3/5
Ownership data is not available for this company yet.

Executive team

Top executives
EBIT / Employee
1.69M
Shares Outstanding
3.58M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Akihiro Nishimura Senior Chief of Internal Audit Office — —
Atsuhito Matsuo Managing Executive Officer & Director — male
Hiroshi Nagata Executive Officer & GM of Senior Business Department — —
Hirotoshi Ito Senior Managing Executive Officer & Director — male
Kenji Uemura President, Chief Executive Officer & Representative Director — male
Koji Yamamoto Senior Executive Officer & Director — male
Ryosuke Nakamoto Executive Officer, GM of Planning &Strategy Department — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities